AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 175 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $482,000 | +46.5% | 51,296 | +19.1% | 0.00% | – |
| Q2 2020 | $329,000 | +30.6% | 43,060 | +5.5% | 0.00% | – |
| Q1 2020 | $252,000 | -78.9% | 40,829 | -58.4% | 0.00% | -100.0% |
| Q4 2019 | $1,196,000 | -20.6% | 98,246 | -24.6% | 0.00% | 0.0% |
| Q3 2019 | $1,506,000 | +20.3% | 130,375 | +4.0% | 0.00% | 0.0% |
| Q2 2019 | $1,252,000 | -39.7% | 125,375 | -22.3% | 0.00% | -50.0% |
| Q1 2019 | $2,078,000 | -30.2% | 161,298 | -17.7% | 0.00% | -33.3% |
| Q4 2018 | $2,976,000 | -53.1% | 195,917 | -38.2% | 0.00% | -50.0% |
| Q3 2018 | $6,339,000 | -31.4% | 316,948 | -33.1% | 0.01% | -33.3% |
| Q2 2018 | $9,243,000 | +7.8% | 473,975 | +11.3% | 0.01% | +12.5% |
| Q1 2018 | $8,578,000 | +78.9% | 425,704 | +17.7% | 0.01% | +60.0% |
| Q4 2017 | $4,794,000 | -8.6% | 361,806 | +27.2% | 0.01% | -16.7% |
| Q3 2017 | $5,247,000 | 0.0% | 284,391 | -0.3% | 0.01% | 0.0% |
| Q2 2017 | $5,247,000 | -4.9% | 285,189 | +16.5% | 0.01% | -25.0% |
| Q1 2017 | $5,518,000 | -41.6% | 244,699 | -9.8% | 0.01% | -38.5% |
| Q4 2016 | $9,445,000 | +36.0% | 271,422 | -4.2% | 0.01% | +30.0% |
| Q3 2016 | $6,943,000 | +2.2% | 283,287 | -0.2% | 0.01% | -9.1% |
| Q2 2016 | $6,792,000 | +100.1% | 283,959 | +95.8% | 0.01% | +120.0% |
| Q1 2016 | $3,394,000 | +137.2% | 145,031 | +206.0% | 0.01% | +150.0% |
| Q4 2015 | $1,431,000 | -12.6% | 47,392 | +15.0% | 0.00% | -33.3% |
| Q3 2015 | $1,637,000 | -36.5% | 41,199 | +10.4% | 0.00% | -40.0% |
| Q2 2015 | $2,578,000 | +46.8% | 37,334 | +16.2% | 0.01% | +25.0% |
| Q1 2015 | $1,756,000 | +20.9% | 32,130 | -5.7% | 0.00% | +33.3% |
| Q4 2014 | $1,452,000 | +9.0% | 34,071 | -18.4% | 0.00% | 0.0% |
| Q3 2014 | $1,332,000 | +92.2% | 41,748 | +24.8% | 0.00% | +50.0% |
| Q2 2014 | $693,000 | +9.1% | 33,442 | +1.9% | 0.00% | 0.0% |
| Q1 2014 | $635,000 | -8.8% | 32,834 | +14.5% | 0.00% | 0.0% |
| Q4 2013 | $696,000 | +51.6% | 28,664 | +34.1% | 0.00% | +100.0% |
| Q3 2013 | $459,000 | +33.0% | 21,378 | +37.9% | 0.00% | 0.0% |
| Q2 2013 | $345,000 | – | 15,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,777,392 | $110,346,000 | 5.31% |
| Opaleye Management Inc. | 200,000 | $7,946,000 | 3.91% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 108,423 | $4,308,000 | 1.58% |
| ASHFORD CAPITAL MANAGEMENT INC | 164,325 | $6,529,000 | 1.53% |
| Endurant Capital Management LP | 94,100 | $3,739,000 | 1.25% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 76,600 | $3,043,000 | 1.15% |
| PYRRHO CAPITAL MANAGEMENT, LP | 32,800 | $1,303,000 | 1.13% |
| AlphaOne Investment Services, LLC | 63,226 | $2,511,000 | 1.07% |
| DELPHI MANAGEMENT INC /MA/ | 131,240 | $5,214,000 | 0.82% |
| CAPITAL GROWTH MANAGEMENT LP | 472,000 | $18,753,000 | 0.60% |